~~<i id='74099C33DE'><strike id='74099C33DE'><tt id='74099C33DE'><pre id='74099C33DE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：leisure time 2025-09-03 03:38:22 - browse：4

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Grail is spending more than ever lobbying Congress

entertainment

hotspot

leisure time

hotspot

focus

AlonestartickunderamicroscopeinalabattheNorthCarolinaMuseumofNaturalSciencesinRaleigh.Doctorsacrosst

WSS

Grail is spending more than ever lobbying Congress

The mammogram wars are not over

Ending health disparities requires full federal government, panel says

Brain 'hot spot' may explain why African Americans feel greater pain

A new study asks: Are we harming blood donors by taking blood?

RaDonda Vaught case: a double standard for nurses, physicians

focus

comprehensive

entertainment

Medical leaders decry Supreme Court decision on affirmative action

New case study details death in closely watched Alzhiemer's trial

Drug repurposing or repositioning? The language matters

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Continuity nursing helped my family in our darkest PICU moments

A new study asks: Are we harming blood donors by taking blood?

In Memoriam: Notable people who died in 2023

As the dark side of IVF slowly comes into focus, even more transparency is needed

United colonoscopy coverage change 'may cost lives,' doctors say

Community addresses injustice for Long Island mothers

hotspot

Timeline: Special counsel's probe into Trump's handling of classified documents

PhRMA sues HHS over Medicare drug price negotiation

Marc Tessier

Behind warning on Apellis’s eye drug lies a conflict of interest

Doctor appointment wait times are getting worse

These geoengineering technologies could help combat the climate crisis, scientists say

leisure time

hotspot

hotspot

focus